{
     "PMID": "2551699",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "19891106",
     "LR": "20141120",
     "IS": "0014-2999 (Print) 0014-2999 (Linking)",
     "VI": "166",
     "IP": "2",
     "DP": "1989 Jul 18",
     "TI": "Regional variations in binding capacities at mu-, delta- and kappa-opioid sites in membrane suspensions from rabbit brain.",
     "PG": "213-7",
     "AB": "The highest maximum binding capacities at the mu-sites of rabbit brain are in the striatum, with intermediate levels in the diencephalon, mesencephalon, cerebellum and cortex and low levels in the pons-medulla and hippocampus. For the delta-site the highest maximum binding capacity is also in the striatum; there are almost equally low levels in the other brain regions. At the kappa-sites the maximum binding capacities are highest in the diencephalon; there are intermediate levels in the cortex and striatum, and low levels in the mesencephalon, cerebellum, hippocampus and pons-medulla. The KD values lack reproducibility; there are no regional variations at the kappa-site as estimated with [3H](-)-bremazocine, but the possibility cannot be excluded that there are regional variations in the KD values for [3H][D-Ala2,MePhe4,Gly-ol5]enkephalin at the mu-site or for [3H][D-Ala2,D-Leu5]enkephalin at the delta-site. It may be important to use saturation analysis in future investigations of the distributions of the binding sites.",
     "FAU": [
          "Petrillo, P",
          "La Regina, A",
          "Sbacchi, M",
          "Tavani, A",
          "Robson, L E",
          "Kosterlitz, H W"
     ],
     "AU": [
          "Petrillo P",
          "La Regina A",
          "Sbacchi M",
          "Tavani A",
          "Robson LE",
          "Kosterlitz HW"
     ],
     "AD": "Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy.",
     "LA": [
          "eng"
     ],
     "GR": [
          "DA 00662/DA/NIDA NIH HHS/United States"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't",
          "Research Support, U.S. Gov't, P.H.S."
     ],
     "PL": "Netherlands",
     "TA": "Eur J Pharmacol",
     "JT": "European journal of pharmacology",
     "JID": "1254354",
     "RN": [
          "0 (Analgesics)",
          "0 (Benzomorphans)",
          "0 (Enkephalins)",
          "0 (Nerve Tissue Proteins)",
          "0 (Receptors, Opioid)",
          "0 (Receptors, Opioid, delta)",
          "0 (Receptors, Opioid, kappa)",
          "0 (Receptors, Opioid, mu)",
          "100929-53-1 (Enkephalin, Ala(2)-MePhe(4)-Gly(5)-)",
          "58822-25-6 (Enkephalin, Leucine)",
          "63631-40-3 (Enkephalin, Leucine-2-Alanine)",
          "65189-64-2 (enkephalinamide-Leu, Ala(2)-)",
          "ISF76M2DBE (bremazocine)"
     ],
     "SB": "IM",
     "MH": [
          "Analgesics/metabolism/pharmacology",
          "Animals",
          "Benzomorphans/metabolism/pharmacology",
          "Binding, Competitive/drug effects",
          "Body Weight/drug effects",
          "Brain Chemistry/*drug effects",
          "Enkephalin, Ala(2)-MePhe(4)-Gly(5)-",
          "Enkephalin, Leucine/analogs & derivatives/metabolism/pharmacology",
          "*Enkephalin, Leucine-2-Alanine/*analogs & derivatives",
          "Enkephalins/metabolism/pharmacology",
          "In Vitro Techniques",
          "Male",
          "Membranes/metabolism",
          "Nerve Tissue Proteins/metabolism",
          "Rabbits",
          "Receptors, Opioid/*drug effects/metabolism",
          "Receptors, Opioid, delta",
          "Receptors, Opioid, kappa",
          "Receptors, Opioid, mu"
     ],
     "EDAT": "1989/07/18 00:00",
     "MHDA": "1989/07/18 00:01",
     "CRDT": [
          "1989/07/18 00:00"
     ],
     "PHST": [
          "1989/07/18 00:00 [pubmed]",
          "1989/07/18 00:01 [medline]",
          "1989/07/18 00:00 [entrez]"
     ],
     "AID": [
          "0014-2999(89)90061-7 [pii]"
     ],
     "PST": "ppublish",
     "SO": "Eur J Pharmacol. 1989 Jul 18;166(2):213-7.",
     "term": "hippocampus"
}